• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在甘草酸与氨基酸及二肽酯的缀合物中发现强效登革病毒NS2B-NS3蛋白酶抑制剂

Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides Esters.

作者信息

Lin Yu-Feng, Lai Hsueh-Chou, Lin Chen-Sheng, Hung Ping-Yi, Kan Ju-Ying, Chiu Shih-Wen, Lu Chih-Hao, Petrova Svetlana F, Baltina Lidia, Lin Cheng-Wen

机构信息

Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, Taiwan.

Division of Hepato-Gastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung 404327, Taiwan.

出版信息

Viruses. 2024 Dec 17;16(12):1926. doi: 10.3390/v16121926.

DOI:10.3390/v16121926
PMID:39772233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11680386/
Abstract

This study investigated a library of known and novel glycyrrhizic acid (GL) conjugates with amino acids and dipeptide esters, as inhibitors of the DENV NS2B-NS3 protease. We utilized docking algorithms to evaluate the interactions of these GL derivatives with key residues (His51, Asp75, Ser135, and Gly153) within 10 Å of the DENV-2 NS2B-NS3 protease binding pocket (PDB ID: 2FOM). It was found that compounds and exhibited unique binding patterns, forming hydrogen bonds with Asp75, Tyr150, and Gly153. Based on the molecular docking data, conjugates with L-glutamic acid dimethyl ester, with β-alanine ethyl ester, and with aminoethantic acid methyl ester were further demonstrated as potent inhibitors of DENV-2 NS3 protease, with IC50 values below 1 μM, using NS3-mediated cleavage assay. Compound was the most potent, with EC50 values of 0.034 μM for infectivity, 0.042 μM for virus yield, and a selective index over 2000, aligning with its strong NS3 protease inhibition. Compound exhibited better NS3 protease inhibition than compound but showed weaker effects on infectivity and virus yield. While all compounds strongly inhibited viral infectivity post-entry, compound also blocked viral entry. This study provided valuable insights into the interactions between active GL derivatives and DENV-2 NS2B-NS3 protease, offering a comprehensive framework for identifying lead compounds for further drug optimization and design as NS2B-NS3 protease inhibitors against DENV.

摘要

本研究调查了一系列已知的和新型的甘草酸(GL)与氨基酸及二肽酯的缀合物,作为登革病毒NS2B - NS3蛋白酶的抑制剂。我们利用对接算法评估这些GL衍生物与登革病毒2型NS2B - NS3蛋白酶结合口袋(PDB ID:2FOM)10 Å范围内的关键残基(His51、Asp75、Ser135和Gly153)之间的相互作用。结果发现,化合物 和 呈现出独特的结合模式,与Asp75、Tyr150和Gly153形成氢键。基于分子对接数据,使用NS3介导的切割试验进一步证明,与L - 谷氨酸二甲酯的缀合物 、与β - 丙氨酸乙酯的缀合物 以及与氨基乙磺酸甲酯的缀合物 是登革病毒2型NS3蛋白酶的有效抑制剂,IC50值低于1 μM。化合物 最有效,其感染性的EC50值为0.034 μM,病毒产量的EC50值为0.042 μM,选择性指数超过2000,与其对NS3蛋白酶的强抑制作用一致。化合物 对NS3蛋白酶的抑制作用比化合物 更好,但对感染性和病毒产量的影响较弱。虽然所有化合物在病毒进入后都强烈抑制病毒感染性,但化合物 还能阻断病毒进入。本研究为活性GL衍生物与登革病毒2型NS2B - NS3蛋白酶之间的相互作用提供了有价值的见解,为鉴定先导化合物以进一步进行药物优化和设计作为针对登革病毒的NS2B - NS3蛋白酶抑制剂提供了一个全面的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/a1b45353f736/viruses-16-01926-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/fed03164f430/viruses-16-01926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/892b47fcd247/viruses-16-01926-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/c917042dfd95/viruses-16-01926-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/fc84ca04a5c9/viruses-16-01926-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/e0cca215db53/viruses-16-01926-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/d8897e1ee0b0/viruses-16-01926-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/d84b70411f02/viruses-16-01926-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/a1b45353f736/viruses-16-01926-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/fed03164f430/viruses-16-01926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/892b47fcd247/viruses-16-01926-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/c917042dfd95/viruses-16-01926-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/fc84ca04a5c9/viruses-16-01926-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/e0cca215db53/viruses-16-01926-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/d8897e1ee0b0/viruses-16-01926-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/d84b70411f02/viruses-16-01926-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/11680386/a1b45353f736/viruses-16-01926-g008.jpg

相似文献

1
Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides Esters.在甘草酸与氨基酸及二肽酯的缀合物中发现强效登革病毒NS2B-NS3蛋白酶抑制剂
Viruses. 2024 Dec 17;16(12):1926. doi: 10.3390/v16121926.
2
Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals.计算机辅助识别登革病毒 NS2B/NS3 蛋白酶抑制剂:一种用于筛选植物化学物质的集成分子建模方法。
J Biomol Struct Dyn. 2024;42(20):11052-11063. doi: 10.1080/07391102.2023.2259496. Epub 2023 Sep 25.
3
Evaluation of methoxyflavones as dengue NS2B-NS3 protease inhibitors: an in silico and in vitro studies.甲氧基黄酮作为登革热NS2B-NS3蛋白酶抑制剂的评价:计算机模拟和体外研究
Mol Divers. 2025 Apr;29(2):1175-1187. doi: 10.1007/s11030-024-10899-5. Epub 2025 Jan 22.
4
Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.发现并研究脯氨酸-甲硫氨酸苯胺作为登革热病毒 NS2B-NS3 蛋白酶抑制剂。
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6549-54. doi: 10.1016/j.bmcl.2013.10.071. Epub 2013 Nov 8.
5
In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.印楝三萜类化合物对登革病毒治疗靶点NS2B-NS3蛋白酶抑制潜力的计算机模拟评估
J Vector Borne Dis. 2016 Apr-Jun;53(2):156-61.
6
Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.作为登革病毒ns2b/ns3蛋白酶潜在抗病毒药物的肽抑制剂的设计与对接研究
Protein Pept Lett. 2014;21(8):815-27. doi: 10.2174/09298665113209990062.
7
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.利用酶原侧的登革病毒NS2B/NS3蛋白酶抑制剂
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.00045-17. Print 2017 May 15.
8
Exploring the antiviral inhibitory activity of Niloticin against the NS2B/NS3 protease of Dengue virus (DENV2).探究尼罗辛对登革热病毒(DENV2)NS2B/NS3 蛋白酶的抗病毒抑制活性。
Int J Biol Macromol. 2024 Oct;277(Pt 1):133791. doi: 10.1016/j.ijbiomac.2024.133791. Epub 2024 Jul 9.
9
3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors.3D-QSAR 和肽杂交物作为登革热病毒 NS2B/NS3 蛋白酶抑制剂的分子对接研究。
Chem Biol Interact. 2024 Jun 1;396:111040. doi: 10.1016/j.cbi.2024.111040. Epub 2024 May 10.
10
Natural DENV-2 NS2B/NS3 protease inhibitors from Myristica cinnamomea King.来自肉桂肉豆蔻(Myristica cinnamomea King)的天然登革热病毒2型NS2B/NS3蛋白酶抑制剂。
Trop Biomed. 2021 Jun 1;38(2):79-84. doi: 10.47665/tb.38.2.044.

引用本文的文献

1
i-DENV: development of QSAR based regression models for predicting inhibitors targeting non-structural (NS) proteins of dengue virus.登革病毒I型:基于定量构效关系的回归模型开发,用于预测靶向登革病毒非结构(NS)蛋白的抑制剂
Front Pharmacol. 2025 Jun 26;16:1605722. doi: 10.3389/fphar.2025.1605722. eCollection 2025.

本文引用的文献

1
The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.NS2B/NS3蛋白酶的抑制作用:治疗登革热和寨卡病毒感染的新治疗契机
Int J Mol Sci. 2024 Apr 16;25(8):4376. doi: 10.3390/ijms25084376.
2
Inhibition of dengue viruses by N-methylcytisine thio derivatives through targeting viral envelope protein and NS2B-NS3 protease.N-甲基胞嘧啶硫代衍生物通过靶向病毒包膜蛋白和 NS2B-NS3 蛋白酶抑制登革病毒。
Bioorg Med Chem Lett. 2024 Feb 1;99:129623. doi: 10.1016/j.bmcl.2024.129623. Epub 2024 Jan 18.
3
Selected Plant Triterpenoids and Their Derivatives as Antiviral Agents.
植物三萜类化合物及其衍生物作为抗病毒药物的研究进展。
Molecules. 2023 Nov 22;28(23):7718. doi: 10.3390/molecules28237718.
4
Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV.将虚拟筛选与顺/反式切割酶分析相结合,可有效揭示针对 SARS-CoV-2 和 MERS-CoV 主要蛋白酶的广谱抑制剂。
Antiviral Res. 2023 Aug;216:105653. doi: 10.1016/j.antiviral.2023.105653. Epub 2023 Jun 14.
5
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide.甘草酸、甘草次酸和甘草次酸单葡萄糖醛酸苷的抗病毒活性综述
Pharmaceuticals (Basel). 2023 Apr 23;16(5):641. doi: 10.3390/ph16050641.
6
Perspectives on the current antiviral developments towards RNA-dependent RNA polymerase (RdRp) and methyltransferase (MTase) domains of dengue virus non-structural protein 5 (DENV-NS5).登革热病毒非结构蛋白 5(DENV-NS5)的 RNA 依赖性 RNA 聚合酶(RdRp)和甲基转移酶(MTase)结构域的当前抗病毒研究进展的观点。
Eur J Med Chem. 2023 Aug 5;256:115416. doi: 10.1016/j.ejmech.2023.115416. Epub 2023 Apr 28.
7
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: vs. approach.评估 NS2B/NS3 蛋白酶抑制剂生物标志物在抑制登革病毒感染方面的潜力:基于结构与基于配体方法的比较。
Front Cell Infect Microbiol. 2023 Feb 14;13:1061937. doi: 10.3389/fcimb.2023.1061937. eCollection 2023.
8
Structure-Based Design, Synthesis, and Biological Evaluation of the Cage-Amide Derived Orthopox Virus Replication Inhibitors.基于结构的笼酰胺衍生正痘病毒复制抑制剂的设计、合成与生物学评价。
Viruses. 2022 Dec 21;15(1):29. doi: 10.3390/v15010029.
9
Amino-Acid-Conjugated Natural Compounds: Aims, Designs and Results.氨基酸缀合天然产物:目标、设计与结果。
Molecules. 2022 Nov 7;27(21):7631. doi: 10.3390/molecules27217631.
10
Recent Advances in Antiviral Activities of Triterpenoids.三萜类化合物抗病毒活性的最新进展
Pharmaceuticals (Basel). 2022 Sep 21;15(10):1169. doi: 10.3390/ph15101169.